Literature DB >> 520769

Clinical use of glucagon and insulin in therapy of fulminant hepatic failure.

K Okita, S Matsuda, K Hata, T Morimoto, M Sasaki, Y Fukumoto, T Kodama, T Takemoto.   

Abstract

We have reported 5 cases of fulminant hepatic failure who were treated with a combination of glucagon and insulin. Marked improvement of hepatic coma was characteristically noted in all cases.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 520769     DOI： 10.1007/BF02773734

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN： 0435-1339


  6 in total

1.  Hepatotrophic effects of pancreatic and gastrointestinal hormones in the rat in vivo and in vitro.

Authors:  U Junge; W Creutzfeldt
Journal:  Ciba Found Symp       Date:  1977

2.  Effect of insulin and glucagon on fulminant murine hepatitis.

Authors:  M Farivar; J R Wands; K J Isselbacher; N L Bucher
Journal:  N Engl J Med       Date:  1976-12-30       Impact factor: 91.245

3.  Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma.

Authors:  T M Chang
Journal:  Lancet       Date:  1972-12-23       Impact factor: 79.321

4.  Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

Authors:  A G Redeker; H S Yamahiro
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

5.  Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy.

Authors:  P B Soeters; J E Fischer
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

6.  Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon.

Authors:  M L Bucher; M N Swaffield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205
  6 in total
  7 in total

1.  Insulin and glucagon therapy of acute hepatic failure.

Authors:  K Fujiwara; I Ogata; Y Sato; T Tomiya; Y Ohta; Y Oka; S Nagoshi; S Yamada; N Masaki; K Takatsuki
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis.

Authors:  Y Motoo; N Sawabu; H Watanabe; T Okai; Y Nakanuma
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

3.  The effect of insulin and glucagon on the insulin receptor of cultured hepatoma cells.

Authors:  H Sugaya; S Ozaki
Journal:  Gastroenterol Jpn       Date:  1986-08

4.  Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.

Authors:  K Okita; S Matsuda; T Hanta; M Yasunaga; K Sanuki; T Takemoto
Journal:  Gastroenterol Jpn       Date:  1987-10

5.  Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.

Authors:  G M Woolf; A G Redeker
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

Review 6.  Severe acute hepatitis A associated with acute pure red cell aplasia.

Authors:  S Tomida; Y Matsuzaki; M Nishi; T Ikegami; T Chiba; M Abei; N Tanaka; T Osuga; Y Sato; T Abe
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

7.  Glucagon in the metabolic and nutritional management after total pancreatectomy--a case report.

Authors:  M Hirota; S Ikei; M Mishima; K Mori; K Sakamoto; T Yamane; K Idegami; S Katafuchi; H Kiyohara; Y Nakashima
Journal:  Jpn J Surg       Date:  1989-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.